A Phase 2, Multicenter, Randomized, Blinded, Controlled Study of NV-101 for Safety and Efficacy in Pediatric Dental Patients Undergoing Mandibular and Maxillary Procedures

Raybould, Ted (PI)

Oral Health Science

Status	Finished
Effective start/end date	4/15/05 → 4/30/07

Funding

Nova Pharmaceuticals: $8,472.00

1 Finished

A Phase 3, Multicenter, Randomized, Blinded, Controlled Study of NV-101 for Safety and Efficacy in Pediatrics Patients Undergoing Simple Dental Procedures (Protocol No. NOVA 05-PED) 5-9 year old SCOPE
Novak, M.
4/15/05 → 4/30/07
Project: Research project